# Comparing Immune Responses to Topical Imiquimod

> **NCT04809662** · — · TERMINATED · sponsor: **University of California, Davis** · enrollment: 6 (actual)

## Conditions studied

- Actinic Keratoses

## Interventions

- **DRUG:** Imiquimod

## Key facts

- **NCT ID:** NCT04809662
- **Lead sponsor:** University of California, Davis
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2021-03-16
- **Primary completion:** 2023-11-07
- **Final completion:** 2023-11-07
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** PI failed to submit the study for continuing review to IRB, failed to respond.
- **Last updated:** 2024-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04809662

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04809662, "Comparing Immune Responses to Topical Imiquimod". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04809662. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*